Andrew Staron, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MD, New York Medical College




Andrew Staron, MD is an Instructor of Medicine in Hematology & Medical Oncology at the Boston University School of Medicine. He was appointed to the position after completing his residency at the Boston University Medial Center. During his residency, he was the Wellness Committee's Co-chair in the division of Internal Medicine. Dr. Staron has past experience as a tutor and teaching assistant and currently lectures on general internal medicine during morning ambulatory conferences.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Staron A, Verma K, Sanchorawala V. Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis. Br J Haematol. 2022 May 02.View Related Profiles. PMID: 35499208
     
  2. Staron A, Zheng L, Doros G, Connors LH, Mendelson LM, Joshi T, Sanchorawala V. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021 08 04; 11(8):139.View Related Profiles. PMID: 34349108; DOI: 10.1038/s41408-021-00529-w;
     
  3. Staron A, Connors LH, Zheng L, Doros G, Sanchorawala V. Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities. Blood Cancer J. 2020 11 10; 10(11):118.View Related Profiles. PMID: 33173025; DOI: 10.1038/s41408-020-00385-0;
     
  4. Hughes DM, Staron A, Sanchorawala V. A pharmacist's review of the treatment of systemic light chain amyloidosis. J Oncol Pharm Pract. 2021 Jan; 27(1):187-198.View Related Profiles. PMID: 33028132
     
  5. Staron A, Burks EJ, Lee JC, Sarosiek S, Sloan JM, Sanchorawala V. Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis. Blood Adv. 2020 03 10; 4(5):880-884.View Related Profiles. PMID: 32130406; DOI: 10.1182/bloodadvances.2019001331;
     
  6. Staron A, Kataria Y, Murray DL, Sloan JM, Sanchorawala V. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. Am J Hematol. 2020 02; 95(2):E45-E48.View Related Profiles. PMID: 31736101
     
  7. Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala V. A new era of amyloidosis: the trends at a major US referral centre. Amyloid. 2019 Dec; 26(4):192-196.View Related Profiles. PMID: 31306033
     
  8. Qualls DA, Lewis GD, Sanchorawala V, Staron A. Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature. Am J Transplant. 2019 11; 19(11):3185-3190.View Related Profiles. PMID: 31207062
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 8 publications over 4 distinct years, with a maximum of 3 publications in 2019 and 2020

YearPublications
20193
20203
20211
20221


2014 Wellsford and Mildred Clark Medical Memorial: Scholarship Award
2014 Dr. Frank and Florence Marino Scholarship Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Amyloidosis
Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map


Staron's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department